MedTrace Logo

Discordant Hormonal Status of Breast Cancer.

NCT01943032 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 105

Last updated 2013-09-20

No results posted yet for this study

Summary

The purpose of this study is to determine discordant hormonal status of primary breast tumor and metastatic breast cancer cells at regional lymph nodes in node positive breast cancer patients.

Conditions

  • Malignant Neoplasm of Breast.

Sponsors & Collaborators

  • National Cancer Institute, Thailand

    lead OTHER_GOV

Principal Investigators

  • AKANIST PIYAPANT, MD.,FRCST. · National Cancer Institute, Thailand

Eligibility

Min Age
25 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2011-04-30
Completion
2012-04-30

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01943032 on ClinicalTrials.gov